Joel Neal
6 Podcast Episodes
Key Presentations on Lung Cancer from the 2021 ASCO Annual Meeting with Dr Joel Neal
Key Presentations on Lung Cancer from the 2021 ASCO Annual Meeting with Dr Joel Neal
Dr Joel Neal from Stanford University in Stanford, California, discusses key presentations on lung cancer from the 2021 ... Read more
10 Aug 2021
•
56mins
ASCO 2012 LC Highlights: Dr. Joel Neal on Molecular Targets in Squamous NSCLC (audio)
ASCO 2012 LC Highlights: Dr. Joel Neal on Molecular Targets in Squamous NSCLC (audio)
Dr. Joel Neal presents interesting early data demonstrating that squamous NSCLC often features identifiable molecular ma... Read more
21 Sep 2012
•
4mins
Similar People
Ross Camidge
David Spigel
Vivek Mehta
Ezra Cohen
Tom Lynch
Eric Klein
Jared Weiss
John Heymach
Leora Horn
Alice Shaw
Rogerio Lilenbaum
Suresh Ramalingam
Jeffrey Bradley
Benjamin Levy
Kathleen Moore
ASCO 2012 LC Highlights: Dr. Joel Neal on the SELECT Trial of Tarceva (Erlotinib) As Adjuvant Therapy for EGFR Mutation-Positive Advanced NSCLC (audio)
ASCO 2012 LC Highlights: Dr. Joel Neal on the SELECT Trial of Tarceva (Erlotinib) As Adjuvant Therapy for EGFR Mutation-Positive Advanced NSCLC (audio)
Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resec... Read more
16 Sep 2012
•
4mins
ASCO 2012 LC Highlights: Dr. Joel Neal on the LUX-Lung 3 Trial of Afatinib vs. Chemo for EGFR Mutation-Positive Advanced NSCLC (audio)
ASCO 2012 LC Highlights: Dr. Joel Neal on the LUX-Lung 3 Trial of Afatinib vs. Chemo for EGFR Mutation-Positive Advanced NSCLC (audio)
Dr. Joel Neal covers results with afatinib, an irreversible "pan-HER inhibitor", compared with standard chemo for patien... Read more
12 Sep 2012
•
5mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
ASCO 2012 LC Highlights: Dr. Joel Neal on the MEK Inhibitor Selumetinib in KRAS Mutation-Positive NSCLC (audio)
ASCO 2012 LC Highlights: Dr. Joel Neal on the MEK Inhibitor Selumetinib in KRAS Mutation-Positive NSCLC (audio)
Dr. Joel Neal reviews the favorable results with chemo combined with the novel targeted therapy selumetinib, a MEK inhib... Read more
11 Sep 2012
•
5mins
ASCO 2012 LC Highlights: Dr. Joel Neal on Anti-PD-1 Immunotherapy for Advanced NSCLC (audio)
ASCO 2012 LC Highlights: Dr. Joel Neal on Anti-PD-1 Immunotherapy for Advanced NSCLC (audio)
Dr. Joel Neal describes the very encouraging data on anti-PD-1 immunotherapy with BMS-936558/MDX-1106 in patients with a... Read more
5 Sep 2012
•
7mins
